A randomized phase 1 study of testosterone replacement for patients with low-risk castration-resistant prostate cancer.
A randomized phase 1 study of testosterone replacement for patients with low-risk castration-resistant prostate cancer. Eur Urol. 2009 Jul; 56(1):97-103.